{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T21:20:58Z","timestamp":1777929658499,"version":"3.51.4"},"reference-count":40,"publisher":"SAGE Publications","issue":"10","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Photobiomodulation, Photomedicine, and Laser Surgery"],"published-print":{"date-parts":[[2019,10]]},"abstract":"<jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>A review of photobiomodulation (PBM) in Alzheimer's dementia is submitted. The addition of PBM in neurodegenerative diseases is a dual modality that is at present gaining traction as it is safe, antiviral, and anti-inflammatory for treating neurodegeneration with photons that stimulate mitochondria increasing adenosine triphosphate and proteasomes increasing misfolded protein removal. Neurofeedback provides neural plasticity with an increase in brain-derived nerve factor mRNA and an increase in dendrite production and density in the hippocampus coupled with overall growth in dendrites, density, and neuronal survival.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Alzheimer's disease pathophysiology is the accumulation of hyperphosphorylated tau protein neurofibrillary tangles and subsequently amyloid-beta (A\u03b2) plaques. PBM and neurobiofeedback (NBF)address the multiple gene expression and upregulation of multiple pathogenic pathway inflammation, reactive oxidative stress, mitochondrial disorders, insulin resistance, methylation defects, regulation of neuroprotective factors, and regional hypoperfusion of the brain. There is no human evidence to suggest a clinical therapeutic benefit from using consistent light sources while significantly increasing safety concerns.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A PBM test with early- to mid-Alzheimer's was reported in 2017, consisting of a double-blind, placebo-controlled trial in a small pilot group of early- to mid-dementia subjects under Institutional Review Board (IRB)-approved Food and Drug Administration (FDA) Clinical Trial.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>PBM-treated subjects showed that active treatment subjects tended to show greater improvement in the functioning of the executive: clock drawing, immediate recall, practical memory, and visual attention and task switching (Trails A&amp;B). A larger study using the CerebroLite helmet in Temple Texas again of subjects in a double-blind, placebo-controlled IRB-approved FDA Clinical Trial demonstrated gain in memory and cognition by increased clock drawing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Next-generation trials with the Cognitolite for Parkinson's disease subjects will incorporate the insights regarding significant bilateral occipital hypocoherence deficits gained from the quantitative EEG analyses. Future applications will integrate noninvasive stimulation delivery, including full-body and transcranial and infrared light with pulsed electromagnetic frequencies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1089\/photob.2019.4685","type":"journal-article","created":{"date-parts":[[2019,10,24]],"date-time":"2019-10-24T15:37:06Z","timestamp":1571931426000},"page":"623-634","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":31,"title":["Treatment of Neurodegeneration: Integrating Photobiomodulation and Neurofeedback in Alzheimer's Dementia and Parkinson's: A Review"],"prefix":"10.1177","volume":"37","author":[{"given":"Marvin H.","family":"Berman","sequence":"first","affiliation":[{"name":"Quietmind Foundation, Elkins Park, Pennsylvania."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trent W.","family":"Nichols","sequence":"additional","affiliation":[{"name":"CNDD, Hanover, Pennsylvania."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2019,10,23]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jphotobiol.2011.08.009"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jphotobiol.2005.05.005"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2018.05.023"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.21767\/2171-6625.1000176"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbacli.2016.09.002"},{"key":"e_1_3_3_7_2","volume-title":"The End of Alzheimer's: The First Program to Prevent and Reverse Cognitive Decline","author":"Bredesen D","year":"2017","unstructured":"Bredesen D. The End of Alzheimer's: The First Program to Prevent and Reverse Cognitive Decline. New York: Penguin: Random House, 2017."},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-815305-5.00032-4"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2014.00070"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.4172\/2161-0460.1000159"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4011"},{"key":"e_1_3_3_12_2","doi-asserted-by":"crossref","unstructured":"Servic K. Another major drug candidate targeting the brain plaques of Alzheimer's disease has failed. What's left? Available at: https:\/\/www.sciencemag.org\/news\/2019\/03\/ (Last accessed August28 2019).","DOI":"10.1126\/science.aax4236"},{"key":"e_1_3_3_13_2","doi-asserted-by":"crossref","unstructured":"Underwood E. Why the big change to Lilly's Alzheimer's trial is not evidence its drug has failed again. Available at: https:\/\/www.sciencemag.org\/news\/2016\/03 (Last accessed August28 2019).","DOI":"10.1126\/science.aaf9811"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1186\/alzrt232"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gks537"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.10394"},{"key":"e_1_3_3_17_2","unstructured":"Delaney D. Why Healthcare is continuing its shift to the cloud. Health Data Management. April 27 2017. Available at: https:\/\/www.healthdatamanagement.com\/opinion\/why-healthcare-is-continuing-its-shift-to-the-cloud (Last accessed August28 2019)."},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1186\/alzrt269"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1089\/pho.2015.3986"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.4062\/biomolther.2014.083"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jphotobiol.2013.02.015"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-15357-x"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.21767\/2171-6625.1000176"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2018.05.023"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinph.2013.05.001"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1089\/pho.2016.4227"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12975-014-0334-1"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2010.05.008"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2012.05.006"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/2525967"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-10-356"},{"key":"e_1_3_3_32_2","unstructured":"Goodwin TJ. Physiological and molecular genetic effects of time-varying electromagnetic fields on human neuronal cells. Available at https:\/\/ntrs.nasa.gov\/archive\/nasa\/casi.ntrs.nasa.gov\/20030075722.pdf (Last accessed September30 2019)."},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-15754-2"},{"key":"e_1_3_3_34_2","volume-title":"Autobiography of a Theory: Developing a Theory of Living Human Systems and its Systems-Centered Practice (International Library of Group Analysis, 11), 1st ed","author":"Agazarian YM","year":"2000","unstructured":"Agazarian YM, , Gantt S. Autobiography of a Theory: Developing a Theory of Living Human Systems and its Systems-Centered Practice (International Library of Group Analysis, 11), 1st ed. London: Jessica Kingsley Publisher, 2000."},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1080\/87565641.2011.619241"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.3389\/fnhum.2014.00529"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2018.00579"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2018.00048"},{"key":"e_1_3_3_39_2","first-page":"713","article-title":"Evaluation of the efficacy of low-level light therapy using 1072nm infrared light for the treatment of herpes simplex labialis","volume":"38","author":"Dougal G","year":"2013","unstructured":"Dougal G, , Lee SY. Evaluation of the efficacy of low-level light therapy using 1072nm infrared light for the treatment of herpes simplex labialis. Clin Exp Dermtol, 2013; 38:713\u2013718.","journal-title":"Clin Exp Dermtol"},{"key":"e_1_3_3_40_2","first-page":"859","article-title":"The value of Clock Drawing in identifying executive cognitive dysfunction in people with normal MMSE score","volume":"167","author":"Angela J","year":"2002","unstructured":"Angela J, , Tench S, , Baker V. The value of Clock Drawing in identifying executive cognitive dysfunction in people with normal MMSE score. Can Med Assoc J, 2002; 167:859\u2013864.","journal-title":"Can Med Assoc J"},{"key":"e_1_3_3_41_2","unstructured":"Laser safety. Wikipedia. Available at: https:\/\/en.wikipedia.org\/wiki\/Laser_safety (Last accessed October14 2019)."}],"container-title":["Photobiomodulation, Photomedicine, and Laser Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/photob.2019.4685","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/photob.2019.4685","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/photob.2019.4685","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T23:46:36Z","timestamp":1777679196000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/photob.2019.4685"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":40,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["10.1089\/photob.2019.4685"],"URL":"https:\/\/doi.org\/10.1089\/photob.2019.4685","relation":{},"ISSN":["2578-5478","2578-5478"],"issn-type":[{"value":"2578-5478","type":"print"},{"value":"2578-5478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10]]}}}